Related Experiment Video
Updated: Sep 27, 2026

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein
Published on: June 12, 2018
Antisense Sp1 oligodeoxynucleotide decreases telomerase activity by inhibiting hTERT mRNA expression in Jurkat T
Jian-Xin Pang1, Xi-Yuan Cheng, Wei Xu
1Institute of Pharmaceutic Sciences, First Military Medical University, Guangzhou 510515, China. pjx@fimmu.com
Aim:
To study the effects of transcriptional factor Sp1 antisense oligodeoxynucleotide (ODN) on telomerase activity and human telomerase reverse transcriptase (hTERT) expression.
Methods:
Antisense oligodeoxynucleotide (ODN) was designed to inhibit Sp1 expression and transferred to Jurkat T cells by lipofectamin. Telomerase PCR-ELISA was used to detect telomerase activity. RT-PCR analysis was used to assess the mRNA expression of Sp1 and hTERT, and Western blot was used to analyze the levels of Sp1 protein.
Results:
Treatment of Jurkat T cells with Sp1 antisense ODN (1 micromol/L) dramatically reduced Sp1 mRNA and protein levels. The inhibition rate was 44.8 % (P <0.05) and 57 % (P <0.01), respectively. Following the transcriptional factor Sp1 functionally altering, hTERT mRNA expression were suppressed with a 43.7 % inhibition rate (P <0.01). A dose-dependent inhibition of telomerase activity by antisense Sp1 ODN was also discovered. From 0.25 to 2.0 micromol/L, telomerase activity was reduced from 27.1 % to 64.6 %.
Conclusion:
Antisense Sp1 ODN decreases telomerase activity by inhibiting hTERT mRNA expression in Jurkat T cells.
Insights
Antisense Sp1 oligodeoxynucleotide (ODN) effectively reduces Sp1 expression in Jurkat T cells. This inhibition leads to decreased human telomerase reverse transcriptase (hTERT) mRNA expression and telomerase activity.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Telomerase plays a crucial role in cell immortality and is often upregulated in cancer.
- Sp1 is a transcription factor that can regulate the expression of hTERT, a key component of telomerase.
- Targeting Sp1 offers a potential strategy to inhibit telomerase activity.
Purpose of the Study:
- To investigate the impact of Sp1 antisense oligodeoxynucleotide (ODN) on telomerase activity.
- To examine the effect of Sp1 inhibition on human telomerase reverse transcriptase (hTERT) expression.
Main Methods:
- Jurkat T cells were treated with Sp1 antisense ODN using lipofectamine.
- Telomerase activity was measured using Telomerase PCR-ELISA.
- Sp1 and hTERT mRNA levels were assessed by RT-PCR, and Sp1 protein levels by Western blot.
Main Results:
- Sp1 antisense ODN significantly reduced Sp1 mRNA and protein levels in Jurkat T cells.
- hTERT mRNA expression was suppressed by approximately 43.7% (P <0.01).
- A dose-dependent inhibition of telomerase activity was observed, with reductions ranging from 27.1% to 64.6%.
Conclusions:
- Antisense Sp1 ODN effectively inhibits Sp1 expression in Jurkat T cells.
- The inhibition of Sp1 leads to decreased hTERT mRNA expression.
- Sp1 antisense ODN reduces telomerase activity, suggesting a therapeutic target for cancers with high telomerase expression.
Related Concept Videos
Telomeres and Telomerase
Replicative Cell Senescence
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
